Sun Pharma arm- SPARC application for cancer drug Taclantis rejected by USFDA Medical Dialogues Bureau12 Feb 2020 1:10 PM IST"The company has received a Complete Response Letter (CRL) from the United States Food & Drug Administration (USFDA) for the new drug application...
J B Chemicals Gujarat unit gets EIR from USFDA Medical Dialogues Bureau12 Feb 2020 1:03 PM ISTThe company has received EIR from the United States Food and Drug Administration (USFDA) for its newly set up and commissioned solid oral dosage forms...
Zydus Cadila gets USFDA nod for Fluocinonide cream to treat skin conditions Medical Dialogues Bureau12 Feb 2020 12:51 PM ISTFluocinonide cream USP, 0.1 per cent, approved by USFDA is indicated to treat a variety of skin conditions such as psoriasis, eczema, dermatitis,...
Sanofi asks US court to halt diabetes drug patent fight with Mylan Medical Dialogues Bureau12 Feb 2020 10:30 AM IST In a stay application filed on Friday, Sanofi said a recent U.S. Court of Appeals for the Federal Circuit decision upholding the invalidation of two...
Cipla arm inks pact for anti-psychotic drug Quetiapine Farhat Nasim11 Feb 2020 12:15 PM ISTNew Delhi: Cipla Medpro South Africa (Pty) Ltd, a wholly-owned subsidiary of Cipla Ltd, India, has recently concluded an exclusive agreement securing...
Cadila Healthcare Ahmedabad facility gets EIR from USFDA Medical Dialogues Bureau11 Feb 2020 12:09 PM IST The company's topical manufacturing facility at Ahmedabad has received an EIR from the United States Food and Drug Administration (USFDA) signifying...
Zealand Pharma to acquire insulin pump maker Valeritas for USD 23 million Medical Dialogues Bureau11 Feb 2020 11:30 AM ISTThe agreement with Zealand Pharma, which was reached following a robust and extensive marketing process, provides total cash consideration of $23...
Roche Alzheimers disease drug fails to meet primary goal Medical Dialogues Bureau11 Feb 2020 11:30 AM ISTBasel: Roche, recently announced that the gantenerumab arm of Phase II/III DIAN-TU-001 study did not meet its primary endpoint in people who have an...
Nestle invests $200 million more in Aimmune after peanut allergy drug approval Medical Dialogues Bureau10 Feb 2020 8:05 PM IST(Reuters) - Aimmune Therapeutics Inc said on Wednesday the health science arm of Nestle SA will invest an additional $200 million, days after the...
JB Chemicals Gujarat unit passes USFDA inspection with one observation Medical Dialogues Bureau10 Feb 2020 8:04 PM ISTNEW DELHI: JB Chemicals and Pharmaceuticals on Monday said its Gujarat unit has passed the US health regulator's periodical inspection with one minor...
Cipla acquires 4 key brands from Wanbury for up to Rs 89 crore Medical Dialogues Bureau10 Feb 2020 8:00 PM ISTNew Delhi: Drug firm Cipla on Saturday said it has acquiredfourbrandsfrom Wanbury Ltdto strengthen its presence in the women's health segment. ...
Cipla acquires 4 nutrition products from Wanbury for Rs 89 crore Farhat Nasim10 Feb 2020 11:58 AM ISTNew Delhi: Homegrown pharma firm Cipla on Saturday announced the acquisition of nutrition products portfolio from Wanbury Ltd. The company has...
